SL
Sabella Lauren M
Directeur Commercial
OtherF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Sabella Lauren M, Directeur Commercial. Officer active across 3 companies, notably Acorda Therapeutics INC. Cumulatively, 11 reports have been recorded. History available since 3 September 2021. The latest transaction was filed on 15 July 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sabella Lauren M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
11,896 股@ US$3.85100.0% 占其流量Common Stock, $0.01 Par ValueSEC:0000950170-25-096736:0
16,407 股@ US$5.1037.1% 占其流量Common Stock, $.01 Par ValueSEC:0000950170-25-047092:0
722 股@ US$3.091.0% 占其流量Common Stock, $0.01 Par ValueSEC:0000950170-24-084407:0
129,000 股0Common Stock, $.01 Par ValueSEC:0000950170-24-062065:0
17,084 股@ US$4.6334.7% 占其流量Common Stock, $.01 Par ValueSEC:0000950170-24-038816:0
711 股@ US$3.090.9% 占其流量Common Stock, $0.01 Par ValueSEC:0001209191-24-002740:0
23,250 股0Common Stock, $.01 Par ValueSEC:0001209191-23-032730:0
210,000 股0Restricted Stock UnitSEC:0001209191-23-032031:0
14,184 股@ US$4.2326.3% 占其流量Common Stock,$.01 par valueSEC:0001209191-23-029518:0
1,511 股@ US$0.3985.1% 占其流量Common StockSEC:0001209191-22-048948:0
1,511 股@ US$4.3890.2% 占其流量Common StockSEC:0001209191-21-055101:0
About Sabella Lauren M
Sabella Lauren M is Directeur Commercial. They have 11 filings in total, all in the recent sample, involving Mannkind CORP, MANNKIND CORP and Acorda Therapeutics INC, with filings from 2021-09-08 to 2025-07-17. The modal transaction nature is Attribution, and the buy and sell amounts shown for the recent filings are EUR 0 each.